Physiomics Plc announced that the Board anticipates that the contracts for these two projects will be signed in FY24, the majority of the revenue is now expected be recognised in the Company's next financial year ending 30 June 2025, and accordingly the Board's expectations for FY25 revenues have been correspondingly increased.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 GBX | +5.19% | +9.23% | -11.25% |
12:33pm | Physiomics Secures Virtual Tumor Platform Contract | MT |
11:30am | Physiomics inks contract with old client worth GBP186,000 | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.25% | 2.35M | |
-0.72% | 138B | |
+20.01% | 76.95B | |
+17.91% | 39.13B | |
-13.99% | 38.66B | |
-1.28% | 30.13B | |
-16.12% | 15.48B | |
+8.95% | 14.71B | |
+10.66% | 10.58B | |
-21.24% | 4.15B |
- Stock Market
- Equities
- PYC Stock
- News Physiomics Plc
- Physiomics Plc Increases Revenue Expectation for the Year 2025